President Donald Trump on Tuesday, May 13 announced a $600 billion “strategic partnership” with Saudi Arabia to invest in the United States, part of a series of what he called “transformative deals secured in Saudi Arabia.”
Those deals include a $5.8 billion investment by a healthcare company, Shamekh IV Solutions, that Trump said will spend a portion in Michigan.
It’s not yet clear how much of the $5.8 billion is planned for the state.
Not much information is available about the company online. The only contact information listed on its website is a Wilmington, Delaware address.
Requests for comment to Gov. Gretchen Whitmer’s office were not returned as of the time of publication. Shamekh IV Solutions could not be reached.
Trump said only that the investment will include “a plant in Michigan to launch a high-capacity IV fluid facility.”
The second-term president began a four-day Middle East trip on Tuesday in Saudi Arabia, with a focus on economic agreements.
RELATED: Saudi crown prince welcomes Trump as he begins 4-day Middle East tour
In his fact sheet announcement shared Tuesday morning, Trump described the $600 billion investment as one creating economic ties “that will endure for generations” and representing a “new golden era of partnership” between the two countries.
“The first deals under the announcement strengthen our energy security, defense industry, technology leadership and access to global infrastructure and critical minerals.”
Among those mentioned by Trump is the $5.8 billion healthcare industry investment by Shamekh IV Solutions, LLC, an intravenous fluid (IV) manufacturer.
In a May 13 press release, the company said the investment is part of a “global plan for a series of pharmaceutical manufacturing facilities” aligned with Trump’s May 5 executive order, which aims to increase domestic production of pharmaceuticals by reviewing regulations.
The LLC said the first of the planned facilities will be established in the Kingdom of Saudi Arabia, with groundbreaking scheduled for the fall of 2025.
“By establishing state-of-the-art manufacturing facilities in Saudi Arabia and across the Americas, we are reducing dependency on fragile global supply networks and ensuring a resilient, reliable flow of essential medical products,” the company wrote.
It does not mention how much will be invested in Michigan.
The release includes mention of Detroit. A separate LinkedIn account for the company has a Bloomfield Hills, Michigan address listed.
The company pledged to prioritize hiring and training local talent and investing in workforce development programs.
The investment announcements by Trump also include a nearly $142 billion defense sales agreement between the U.S. and Saudi Arabia to provide weapons equipment and services from “over a dozen U.S. defense firms.”
